commercial-phases_LBB_phase-4_market-clearance_color_800x800
Phase 4

Market Clearance

We help you turn authorization into readiness. Clearance opens the market, but reimbursement, pricing, and a prepared commercial team determine whether your device gains traction.

Phase overview

Market Clearance begins when the FDA grants clearance or approval and you are authorized to market your device. The regulatory decision opens the door to commercial activity but doesn’t guarantee commercial success. Reimbursement, pricing and contracting, sales enablement, and channel readiness all need to be in place before clearance can turn into revenue. This is the phase where the work done during review is finalized and activated.


What happens in this phase

Each phase draws on a different combination of our disciplines and sub-disciplines. These are the ones that turn regulatory authorization into commercial readiness.

Reimbursement

Payer engagement led to secure coverage and a clear economic pathway before the first order.

Pricing

Pricing finalized and contracting approach defined for target accounts.

Health System Access

Value analysis committee, IDN, and GPO strategies activated for priority accounts.

Launch Planning

Launch readiness confirmed, with your internal team and channel partners prepared for coordinated market entry.

Marketing Programs

Sales enablement tools, objection handling, and evidence summaries delivered to the field team.

Brand Strategy

Positioning and messaging aligned to the cleared indication and claims.


AdobeStock_1016327132_Color_800x800
What you walk away with

You leave Market Clearance with payer engagement underway, pricing and contracting finalized, and health system strategies active for priority accounts. Your internal team and channel partners are prepared for a coordinated market entry, your field team is equipped with sales enablement tools, and your positioning reflects exactly what the clearance permits.


Why this phase matters

Clearance is often mistaken for the finish line. It authorizes commercial activity, but it doesn’t mean clinicians will change practice, payers will cover the device, or accounts will buy it. Companies that treat clearance as a starting point, with reimbursement resolved and the field team prepared, move faster from authorization to adoption.


commercial-phases_LBB_phase-5_commercial-launch_color_800x800
NEXT PHASE

Commercial Launch

With reimbursement in motion and the team prepared, the program moves into launch, where the device enters the market and traction begins.

Content Card - Just Mighty - Launch - Two Color - Full (1920 x 1080)
Logo - Just Mighty - White Logo (400 x 400)

Your innovation Just Might change the world. But is your strategy up to the task? We help you turn Just Might into Just Mighty.